JAVIER ROBLES GIL
The visceral lesions of diffuse scleroderma have been described by Weiss,1, 2 Lindsay et al.,3 Talbott et al.,4 Barber,5 Stafne et al.,6 Bevans7 and Mathisen et al.8
The existing ignorance regarding the etiology of diffuse scleroderma, as well as of some of its clinical, histologic, radiologic and laboratory aspects, makes it necessary and of great interest to describe new cases, with the results of investigations focused on the problems just mentioned above.
The aim of this paper is not only to contribute to the solution of these problems, but also to investigate the endocrine status of patients with diffuse scleroderma,
GIL JR. CLINICAL STUDY OF VISCERAL LESIONS AND ENDOCRINE DISTURBANCES IN EIGHT CASES OF DIFFUSE SCLERODERMA1. Ann Intern Med. ;34:862–871. doi: 10.7326/0003-4819-34-4-862
Download citation file:
Published: Ann Intern Med. 1951;34(4):862-871.
Endocrine and Metabolism, Rheumatology, Scleroderma.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use